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The levels or mRNAs coding for the myogenic factors MyoD and myogemn were measured tlrin8 synapse formation in dry©loping mu~l~ and 
in adult muscle, after denervation and reinnervatlon ~.nd after muscle paralysis Induced by blocking of n~uromu~cular transmission by neurotosins 
known to alter the density and localization of s~naptie proteins uch as the acetyleholine r ceptor (AChR), Th~ mRNA levels of both factors d~l~nd 
on usalle of the neuromuscular synapses, but they change to different extents, Myogenin mRNA levels decrease drastically with inncrva lion and 
increase strongly following blocking of transmfs~ion whereas the level of MyoD mRNA showed only a small decrease in response to innetvatlon, 
denervation or muscl© paralysis by neurotoxins, Neither mRNA showed a synapse.related cellular distribution. The results uggest that nerve. 
induced ©l~trical muscle activity determines the cellular atio of MyoD and myogenln mRNAs in adult muscle, 
MyoD: Myogenin; mRNA level: Muscle activity~ Rat 
l, INTRODUCTION 
With the characterization f MyoD (myoblast deter. 
ruination geae number 1, MyoDI) [1] considerable in- 
terest has been focussed on the analysis of factors which 
induce myogenesis and the expression of muscle- 
specific structural genes [2]. Other proteins tructurally 
related to MyoD also convert fibroblast (C3H 10TI/2) 
cells into muscle cells and were named myogenin [3,4] 
myf-5 [5] and Mrf-4 [6] also known as herculin [7] or 
myf-6 [8]. It is not yet clear how the expression of 
MyoD and other myogenic factors correlate with the 
subsequent activation of genes that are expressed 
specifically in skeletal muscle. There is evidence that 
MyoD binds directly to regulatory regions of muscle 
specific genes and activates transcription [1]. Putative 
MyoD binding sites containing a CANNTG consensus 
motif have recently been identified on the genes coding 
for different subunits of the nicotinic acetylcholine 
receptor (AChR) [9~11]. Two adjacent CANNTG 
motifs of the chicken AChR ~-subunit gone [I0] and of 
the rat muscle AChR ~,.subunit gone (Numberger et el., 
submitted) are involved in transcriptional ctivation of 
these genes. On the other hand a single MyoD consen- 
sus sequence of the rat muscle AChR ~-subunit gone 
may be necessary to prevent expression i  non-muscle 
cells (Numberger et el., submitted). 
Thus far it is not known whether myogenic factors 
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are also directly involved in the regulation of proteins 
which are localized at the neuromuscular synapse such 
as the AChR. We have measured the changes in the 
levels of MyoD. and myogenic-specific mRNA levels 
during establishment, maintenance and disruption of 
neuromuscular transmission, during which there are 
dramatic changes in the level and spatial distribution of 
synapse-specific mRNAs and proteins. 
2. MATERIALS AND METHODS 
2,1. Isolation and surgery of rat muscle 
Triceps muscles from adult Wistar rats (150-300 g) or rats of 
various postnatal ages, killed with ether, CO2 or decapitated were 
removed and immediately frozen in liquid nitrogen, Denervation and 
reinnervation experiments were performed as described previously 
[12], Pharmacological muscle inactivation was induced either by in- 
jection of botulinum toxin (BoTX) type A into the triceps muscle or 
by chronic blockade of nerve signal conduction in the sciatic nerve us- 
mg tetrodotoxin (TTX) following procedures described by Brenner et 
el. [13] and Witzemann et al, [27], 
2,2, RNA isolation and Northern blot hybridization analysis 
Total RNA was extracted by the guanidinium isothioeyanate 
method [12~14], Samples of RNA (10 ttg each) were denatured in 1 M 
glyoxal and 50% dimethyl sulfoxide [15] electrophoresed on 1,5°70 
agarose gels, transferred [16] to Biodyne membranes (Pall) and 
crosslinked with the UV Stratalinker from Stratagene. Hybridization 
was carried out following the procedure recommended by Pall. The 
membranes were exposed to X.ray film (Kodak X-OMAT) for 1-3 
days at - 70°C using intensifying screens. 
2,3. Hybridization probes 
Hybridization probes were labelled with [a-~aP]dCTP using the 
random primed labelling kit from Boehringer (Mannheim) following 
procedures based on the method of Feinberg and Vogelstein [17]. Ex- 
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Fig. 1. Northern blot hybridization analysis of MyoD and myogenin 
transcripts during postnatal development of rat muscle. (A) MyoD 
mRNA, and (B) myogenin mRNA, show autoradiograms of Northern 
blots which were analyzed by hybridizing with a2P.labelled probes 
(section 2) derived from the corresponding full length cDNAs [1,41. 
The positions of rat ribosomal RNAs are given. (C) Graphic represen- 
tation of  the relative changes of the MyoD and myogenin mRNA 
levels during postnatal development. The relative contents of the 
respective mRNAs (given in arbitrary units) were plotted as a function 
of days after birth; the value for adult muscle is indicated by 'A' .  The 
values are normalized with the values measured at day 1 after birth for 
MyoD and myogenin mRNA. Lines are drawn by eye. 
eet~t of In¢orpora|ed r#dio~¢tlve n~J¢leotide~ wa~ tempered udnll ~pin. 
~olumns trorn Btor~d. The ~peelrte aettvltle~ of lhe pro~e~ ranlled 
from I,.=x tO ~ ¢pm/~= DNA, MyOD I l l  a~d myosenln 141 lpeeltl~ 
probe~ were derived from full lenlllh eDNA done~ kindly provided by 
Dr hussar and Dr Olson. 
2.4. F.vt~h~atlon oy uuloratttoxrams 
Equal Ioad/nj or total RNA wa~ ascertained byczhhltum bromide 
staining ot the agaro~e lids, The ribosomal 18S and 2~t,~ [~,NA band~ 
served as internal standards, Loadtnll increasinll amounts (2-I$ all) or 
total RNA showed a linear increase in~peeiftg hybridlxation signals, 
In ~ome ca~es the .~ame blots were rehybrltllzed usin8 AChR ~ubuni~ 
or acdn mRNA ~pe¢irie probes (Witxemann etal.. in preparation) to
conrlrm the specificity of the observed ehan~es in mRNA content (not 
shown), Autoradiogram5 were ~anned with the dual wavelenlltl~ 
~¢anner f om Shimadzu (CS.910). For d~ndtomelrie evaluation care 
was taken to scan autoradioilrams who~e densities were in the linear 
response ranl~e or the film. 
3. RESULTS 
3.1. MyoD and myogenic mRNA levels changed 
differentially during postnatal development 
Total RNA isolated from lower leg muscle from rat 
was analyzed by Northern blot hybridization. 
Autoradiograms obtained upon hybridization with ~2p. 
labelled MyoD and myogenin specific eDNA-probes are 
shown in Fig, 1A, B. The same blot was hybridized first 
with a MyoD-specific probe and then, after washing, 
with a myogenin-specifie probe, MyoD mRNA remains 
at about the same level during the first 6 weeks of 
postnatal development, myogenin mRNA levels on the 
other hand are higher at birth and decrease drastically 
within the first 3 weeks of development. 
Densitometric evaluation of  the autoradiograms in
Fig. 1 A, B and of additional experiments are sum- 
marized in Fig. IC, where the relative amounts of 
MyoD and myogenin transcripts are plotted as a func- 
tion of postnatal age. The results suggest hat MyoD 
and myogenin mRNAs may respond differently to 
synapse formation and maturation or may follow dif- 
ferent predetermined development programs 
postnatally. 
3.2. Innervation of muscle down-regulates mRNA 
levels of MyoD and myogenin 
To discriminate whether the differences in the 
postnatal changes of MyoD and myogenin mRNA level 
are solely a consequence of myogenic differentiation or 
whether it is also affected by neural signals, total RNA 
was isolated f rom muscles at 7 days of age which were, 
however, denervated atday 1 after birth. MyoD mRNA 
levels, which do not change during normal postnatal 
development, are clearly increased in 7 day (or 11 day, 
not shown) denervated muscles and the normally occur- 
ring postnatal decrease of myogenin specific mRNA is 
prevented by early denervation (Fig. 2A), since the 
myogenin mRNA levels are significantly higher in the 
denervated muscle when compared to the normally in- 
nervated control muscle (Fig. 2B). These results suggest 
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thai both myogenic factors are decreased posmatally in 
response to innervation, Tile specificity or these 
changes is supported by experiments where the same 
RNA ext racts  were  hybr id i zed  w i th  probes  spec i f i c  for  
the AChR subun i t  mRNAs and act in  mRNA (not  
shown}. Denervation of neonatal muscles produced in- 
creased levels of AChR subunit mRNAs  when com- 
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Fig, 2. Postnatal changes in MyoD and myogenin mRNA levels de. 
pend on innervation Total RNA was prepared from postnatal muscle 
one day after birth. At the same time muscle was denervated and the 
total RNA was isolated 7 days later from the denervated and the con. 
tralateral, innervated musc!e as described before [18], RNA 
hybridization analysis was performed as detailed in section 2. (A) 
Autoradiograms show MyoD and myogenin specific mRNAs. Posi. 
tions of the rat ribosomal RNAs are indicated. Below the correspon. 
ding autoradiograms the postnatal stages analyzed are given, dl 
(postnatal day 1) and d8 (posmata.~ day 8). N, RNA isolated from in. 
nervated muscle. D, RNA isolated from denervated muscle. (B) 
Graphic representations of the densitometric evaluation of the 
autoradiograms. Arbitrary units are values normalized using the 
values measured at day 1 after birth for MyoD and myogenin mRNA. 
N (filled bars) and D (open bars) represent RNA from normal and 
denervated muscle at day 1 and day 8 after birth. 
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Fig. 3. MyoD and myogenin mRNA content of adult muscle is down. 
regulated by innervation, Total RNA was isolated from adult, inner. 
rated muscle and from muscle denervated for 7 days and subjected to 
RNA hybridization analysis. Reinnervation e×periments were per- 
formed on rat diaphragm where functional reinnervation lind been 
followed in,parallel on separate muscle preparations [12]. N and D in- 
dicate normal and denervated muscle. Days 7, 14, 30 correspond to 
the time following mechanical nerve crush after which reinnervation 
occurs beginning at day 7 [12]. (A) Autoradiogram representing 
muscular content of MyoD mRNA. (B) Autoradiogram of the blot us. 
ed in (A) but hybridized with a myogenin-specific probe. The posi. 
tions of rat ribosomal RNAs are indicated in (A) and (B), (C) Graphic 
represenlation of the densitometric evaluation of the autograms 
shown in (A) for MyoD (filled bars) and (B) for myogenin (open 
bars). Arbitrary units are values obtained by normalizing with the 
values measured for normal, innervated muscle. 
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muscles whereas reduced amotmts of actin transcripts 
were observed [I81, 
The effect of" denervation and subsequent reinnerva. 
l ion o f  adult muscle on the levels or MyoD and 
myogenin transcripts is shown in Fii~. 3. Following 
denervation MyoD mRNA increases only about 3-5. 
fold (Fig. 3A) whereas myogenin shows a more drastic 
response and increased by at least one order of 
magnitude (Fig. 3B, C). The strong increase in 
myogenin mRNA is quantitatively comparable to the 
increase of AChR or-, -y- and 6-subunit mRNAs follow. 
ing denervation [191. Actin mRNA is, however, 
decreased in denervated muscle [27] again supporting 
the specificity of the observed changes in MyoD and 
myogenin mRNA levels. MyoD as well as myogenin 
mRNA levels decrease as a consequence of reinnerva. 
l ion and reach within about 3 weeks the levels found in 
normally innervated muscle (Fig. 3). Preliminary ex- 
periments demonstrate in addition that both mRNAs 
are reduced to normal levels when the dcnervated mus- 
cle is electrically stimulated. 
3.3. Muscle paralysis caanges MyoD and myogenin 
mRNA levels 
Surgical denervation of the muscle leads not only to 
muscle inactivity, except for fibrillatory electrical ac- 
tivity, but also to the degeneration of  the nerve ter- 
minals which is what may be responsible for denerva- 
lion-like changes (for review see [20]). To  determine the 
effects of  only muscle paralysis, with the 
neuromuscular synapse left structurally intact, nerve- 
induced muscle activity was blocked pharmacologically 
by botulinum toxin (BoTX) and tetrodotoxin (TTX). 
The changes induced by blocking of neuromuscular 
transmission with BoTX (for review see [21]) are sum- 
marized in Fig. 4. Both MyoD (Fig. 4A) and myogenin 
mRNAs (Fig. 4B) are significantly elevated already 2 
days after BoTX administration. Within 7 days o f  
BoTX administration the mRNA levels are increased by 
about 4-fold for MyoD and about 21-fold for myogenin 
which is similar to the increase observed upon surgicai 
denervation of  the muscle. TTX applied by a nerve-cuff 
also induces muscle paralysis. However, in contrast o 
BoTX-blocked muscles, vesicular acetylcholine is still 
released spontaneously with TTX (for review see 
[22,23]). In TTX-blocked muscle MyoD mRNA levels 
increase only slightly and the increase appears to corres- 
pond to the small increase observed in denervated mus- 
cle (Fig. 4A). Myogenin mRNA levels increase more 
drastically but the increase is only 50-60°70 of the 
amount observed after surgical denervation (Fig. 4B). 
3.4. Cellular distribution of MyoD and myogenin 
mRNA 
As a consequence of  innervation the AChR subunit 
mRNAs become mainly restricted to the synaptic 
regions during postnatal development [24]. It was 
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Fig 4. MyoD and myogenin ml~NA content in pharmacologically 
paralysed muscles. Total RNA was isolated from triceps muscle 
paralyscd by injection of botulinum toxin (BoTX) or by chronic 
blockade of impulse conduction i the sciatic nerve with tetrodotoxin 
(TTX) as described in[13]. RNA hybridization a alysis was perform- 
cO using MyoD attd myogenin specific probes. N and D indicate RNA 
isolated from normal and denervated muscle. BoTX indicates mRNA 
content in muscle paralysed by BoTX for 2 and 7 days (2d, 7d) and 
TTX mRNA content in muscle paralysed by TTX for 3, 4 and 7 days 
(3d, 4d, 7d). Autoradiograms were densitometrically scanned and the 
values are shown by the bar histograms. Arbitrary units corresp~.nd 
to values normalized by tl~e values measured for mRNA content of 
normal innervated muscle (A) MyoD mRNA (B) Myogenin mRNA. 
therefore of interest to find out whether innervation 
would also contribute to an uneven cellular distribution 
o f  the MyoD and myogenin mRNAs. Rat diaphragm 
was dissected into synapse-rich and synapse-free muscle 
strips and total RNA was extracted for RNA hybridiza- 
tion analysis. The results show that MyoD and 
myogenin mRNAs are present in approximately equal 
amounts in both muscle regions and thus display an 
uniform cellular distribution (Fig. 5A). Denervation 
causes, for both myogenic factors, an increase in synap- 
tic as well as extrasynaptic resions which corresponds to 
the increases Of the fiaRNA levels present in total muscle 
(Fig. 5B). MyoD and myogenin mRNA expression ap- 
pears therefore not to be confined to specific cellular 
regions such as the innervated region of  the muscle. 
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Fig..'5 Lack of synapse specific location of MyoD and myogenir~ 
n~RNAs in normal and denervated muscle, Rat diaphragm was 
dissected into synapse.rich (J) and synapse.free (E J) muscle strips [12] 
and total RNA was extracted for RNA hybridization analysis. (A) 
Autoradiograms obtained using MyoD and myogenin specific probes 
as indicated and total RNA fi'om normal innervated iaphragm. (B) 
Autoradiograms obtained using MyoD and myogenin specific probes 
as indicated and total RNA from 7 clays denervated diapltragm, 
4. DISCUSSION 
The results how that the muscular contents of MyoD 
and rnyogenin mRNA change in several experimental 
situations where the interaction between the motor 
nerve and muscle is altered, namely during postnatal 
development, denervation, reinnervation, and toxin in- 
duced muscle paralysis. Innervation reduces the mRNA 
levels of both factors, but to different extents. Whereas 
the level of M3,oD shows only relatively small changes 
in abundance when neuromuscular t ansmission is 
established or interrupted (about 2-5-fold) the level of 
myogenin mRNA seems to be more tightly controlled 
by the nerve showing much larger changes (about 20- 
fold). The experiments with neuromuscular block by 
toxins, which leave the nerve-muscle contact physically 
intact but block functional transmission~ suggest that a 
signal related to the nerve-induced lectrical activity of 
the muscle is critical for reduction of MyoD and 
nayogenin mR.NA in adult muscle. The difference in 
mRNA levels between denervated and BoTX paralyzed 
muscle on the one hand and TTX paralyzed muscle on 
the other hand suggests that, in addition, a neutrophic 
factor independent of muscle activity may also be in. 
volved in the red~=ction f myogenin levels. 
A correlation between the time course of either 
MyoD and myogenin mRNA levels and ACIIR subunit 
specific mRNA levels is, if present at all, rather weak. 
Possibly, coordinated changes can be found during 
denervation and reinnervation between myogenin 
mRNA levels in adult muscle and changes in ¢~-, "V- and 
3-subunit mRNAs [27] whereas for ll~e 8- and e-subunit 
mRNAs no correlation is detectable, Also the 
developmental changes are only weakly, if at all, cot- 
related [18I. 
The lack of correspondence b tween mRNA levels of 
myogenic factors and AChR subunit mRNAs in various 
experimental conditions for whole muscle m RNA levels 
is also seen for the cellular distribution of mRNAs, The 
mRNAs of both factors do not show a synapse.related 
cellular distribution, thus an involvement of these 
myogenic factors in the establishment and maintenance 
of synaptic localization of AChR subunit specific 
mRNA is unlikely. 
The differential regulation of the muscular contents 
of MyoD and myogenin mRNAs by nerve-induced mus- 
cle activity indicates that the ratio of these two factors 
could be selectively affected by muscle activity. The fin- 
ding that denervation-triggered activation of AChR- 
genes require de novo synthesis of a transcriptional c- 
tivator [25] raises the question whether myogenic fac- 
tors such as myogenin transactivate AChR-subunit 
genes upon denervation. MyoD binding elements are 
located in the upstream sequences of AChE subtinit 
genes and there is evidence that they regulate the 
transcription of c~. [10] and -y- (Numberger et al., in 
preparation) subunit ~enes in primary muscle cultures. 
The c~-, -y- and ~5.subunit mRNAs seem to be regulated, 
at least partially, by a signal induced by electrical activi- 
ty of the muscle [26,27]. Possibly myogenin, being also 
tightly regulated by electrical muscle activity or a 
related factor, could be involved in the regulation of ex- 
trasynaptic ~- and 3"- and ¢5-subunit mRNA levels in 
adult muscle. 
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